The new Alzheimer’s drug aducanumab does one thing really well…
It clears away amyloid brain plaque.
Unfortunately, clinical trials show there’s something else it doesn’t do very well at all…
It doesn’t help Alzheimer’s patients get better.
So why did the FDA grant accelerated approval, making it the first new Alzheimer’s medication to hit the market in 18 years?
Because the agency and Big Pharma refuse to let go of the long-discredited “amyloid hypothesis.”… Read More
As we get older and memory lapses get more frequent, many of us wonder if it could be the start of Alzheimer’s.
It is especially easy to get worried if you have watched a relative’s mind slip away because of the disease. That’s because Alzheimer’s can run in families.
Dr. Heather M. Snyder is vice president of medical and scientific operations at the Alzheimer’s Association.… Read More
Older Americans often turn to CBD to ease chronic pain or insomnia. But a new study shows that it may also be a potential treatment for Alzheimer’s disease.
The preliminary research, published in the Journal of Alzheimer’s Disease, notes that none of the drugs currently approved by the FDA to treat the brain illness do anything to slow down the disease.… Read More
Mainstream doctors have long touted canola oil as healthy because it’s low in saturated fat.
But as we’ve said for years, this is junk medicine.
It’s possible for canola oil to be healthy…if it’s processed without heat. But it rarely is.
Mass-market canola oils are heated to the point that they produce chemicals called aldehydes. They can build up in your body and lead to heart disease and cancer.… Read More
The U.S. federal government spends nearly $3 billion a year of our tax money on dementia research. Big Pharma spends billions more.[1]
This hugely expensive scientific effort has one goal: To find a way to treat Alzheimer’s disease and to help seniors stay mentally sharp.
So far, the results have been dismal.
We don’t have any treatments that do anything to stop Alzheimer’s, or even slow it down.… Read More
If you have a hard time identifying common smells, it could be an early warning of Alzheimer’s.
That’s the surprising finding of a study at McGill University in Montreal. It looked at whether a simple smell test could reveal someone’s Alzheimer’s risk.
Researchers tested 300 people who had a family history of dementia. All the subjects were given scratch and sniff patches of common smells such as gasoline, bubble gum, and lemon.… Read More